跳至主要内容
临床试验/NCT00646633
NCT00646633已完成不适用

Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors

Jonsson Comprehensive Cancer Center2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2008年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
2
主要终点
Fatigue as measured by the Brief Fatigue Inventory

研究概览

简要总结

Based on the investigators clinical experience in patients with chronic disease (Hui, Hui, and Johnston, 2006; Hays et al 2005), a review of the literature (Johnston, Xiao and Hui 2007), and inspired by Vickers and colleagues (PMID: 15117996), the investigators carry out a pilot study that investigates if acupuncture combined with patient education will relieve fatigue in patients who have completed primary treatment for breast cancer.

详细描述

Patients will be randomly assigned to one of the two groups. Our hypothesis is that patients in the acupuncture/education group will experience greater relief of fatigue than those in the standard care group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is between 18 and 65 years of age
  • Patient has a rounded Brief Fatigue Inventory score of 4 or greater
  • Patient is in a stable clinical condition

排除标准

  • Severe anemia (hemoglobin level less than 9 g/dL, hematocrit level less than 30, decline in hemoglobin of 2 g/dL in the previous month, or active treatment for anemia)
  • Karnofsky Performance Status below 70
  • Acupuncture treatment in the previous 6 months
  • Fatigue before cancer diagnosis
  • Patient is mentally incapacitated or unfit to provide informed consent or participate in an interview
  • Patient has the potential for serious bleeding due to inherited diseases such as hemophilia
  • Patient is taking medications that are either fatigue-inducing or have sedating properties
  • Patient is unavailable by telephone

结局指标

主要结局

Fatigue as measured by the Brief Fatigue Inventory

时间窗: prior to beginning of treatment and after treatment ends. Up to an average of 44 weeks.

次要结局

  • Health-Related Quality of Life (HRQoL) as measured by the SF36(prior to beginning of treatment and after end of treatment. Up to an average of 44 weeks.)
  • Pain as measured by an analog scale(prior to beginning of treatment and after conclusion of treatment. Up to an average of 44 weeks.)
  • Cognitive complaints as measured by the FACT-COG(prior to the beginning of treatment and after end of treatment. Up to an average of 44 weeks.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验